Published research on these studies documented outcomes from approximately 900 adult participants, predominantly individuals classified as clinically obese, though one trial included healthy non-obese volunteers
Its possible to regain some weight after stopping Mounjaro, especially if lifestyle changes arent maintained
Parminder Raina, Christina Wolfson and Susan Kirkland
Many researchers use AOD 9604 as part of multi-peptide protocols
Treatment regimens typically include more frequent injections initially (e.g., three times weekly for two weeks in non-neurological deficiency
In the pool of placebo-controlled trials in adults, severe gastrointestinal adverse reactions occurred more frequently among patients receiving MOUNJARO (5 mg 1.3%, 10 mg 0.4%, 15 mg 1.2%) than placebo (0.9%)